10,893 results match your criteria: "Congenital Myopathies"

Clinical phenotypic presentations associated with LAMA2 deficiency have shown a variety of manifestations. LAMA2 mutations are mainly linked to congenital muscular dystrophy, but there is also mounting evidence suggesting their presence in inflammatory breast cancer, laryngopharyngeal squamous cell carcinoma, and ventricular tachycardia related to coronary artery disease and cardiomyopathy. This study examined the structural and functional impacts of 144 non-synonymous single nucleotide polymorphisms (nsSNPs) within the LAMA2 gene.

View Article and Find Full Text PDF

GNE myopathy, also known as hereditary inclusion body myopathy (HIBM), is a rare genetic muscle disorder marked by a gradual onset of muscle weakness in young adults. GNE myopathy (GNEM) is caused by bi-allelic variants in the UDP--acetylglucosamine 2-epimerase (UDP-GlcNAc 2-epimerase)/-acetylmannosamine kinase (ManNAc kinase) gene (), clinically resulting in the loss of ambulation within 10-20 years from the onset of the initial symptoms. The disease's mechanism is poorly understood and non-invasive biomarkers are lacking, hindering effective therapy development.

View Article and Find Full Text PDF
Article Synopsis
  • Laminin α2-related muscular dystrophies are genetic disorders that can range from severe congenital forms to milder adult-onset versions, both transmitted in an autosomal recessive manner.
  • The report discusses two previously undiagnosed cases of this condition, where children exhibited sudden weakness and elevated creatine kinase levels, triggered by coxsackievirus infections.
  • Genetic testing revealed harmful variations in the LAMA2 gene for both children, confirming their diagnosis and showcasing that acute illness can lead to weakness in these cases.
View Article and Find Full Text PDF

Introduction: Compartment syndrome is a surgical emergency caused by elevated pressure within a closed fascial compartment, leading to compromised tissue perfusion and the potential for irreversible damage if not treated promptly. This report presents a rare case of upper limb compartment syndrome in a COVID-19 patient on anticoagulation therapy following multiple failed venipuncture attempts. This work has been reported in line with the SCARE criteria.

View Article and Find Full Text PDF

encodes the mitochondrial coenzyme A (CoA) transporter localized at the inner mitochondrial membrane. SLC25A42 deficiency leads to a congenital disease with a heterogeneous clinical presentation, including myopathy, developmental delay, lactic acidosis, and encephalopathy. Twenty-one patients have been described so far.

View Article and Find Full Text PDF

c.2011C>T is responsible for congenital scoliosis in a Chinese family.

Biochem Biophys Rep

December 2024

Department of Pediatric Orthopedics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.

Neuromuscular scoliosis can be caused by muscular or nervous system dysfunction resulting from genetic variants. Variation in may cause hypertrophic or dilated cardiomyopathy, skeletal myopathies, or a combination of both; however, scoliosis has rarely been reported. We analyzed a Chinese pedigree with two members suffering from scoliosis.

View Article and Find Full Text PDF

A TPM2 mutation causes congenital myopathy with fibre-type disproportion.

Neurol Sci

October 2024

Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, 80060-900, Brazil.

We report a 9-year-old girl with delayed motor milestones and respiratory difficulty since birth. She presented as a floppy infant, with generalised muscle wasting, dysphagia and facial weakness. The muscle biopsy of the biceps brachii revealed congenital fibre-type disproportion (CFTD) and Sanger sequencing detected a pathogenic variant in the beta-tropomyosin (TPM2) gene (c.

View Article and Find Full Text PDF

Immune-Mediated Megaconial Myopathy: A Novel Subtype of Autoimmune Myopathy.

Neurology

November 2024

From the Department of Neurology (A.R.S., M.M., D.S., T.L.), Mayo Clinic, Rochester, MN; Department of Laboratory Medicine and Pathology (O.N.), Hennepin Healthcare, Minneapolis, MN; Department of Neurology (A.C.M.), University of North Carolina, Chapel Hill; Department of Neurology (A.S.), Northwestern University, Chicago, IL; Division of Rheumatology (C.H.), Department of Medicine, Northwestern University, Chicago, IL; Departments of Laboratory Services (W.F.R.), Neurology (M.M.A.), and Medicine (R.M.A.), Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Center for Gene Therapy (S.N.), Nationwide Children's Hospital, Columbus, OH; and Department of Medicine (P.S.), Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Article Synopsis
  • - This study introduces a new type of autoimmune myopathy called immune-mediated megaconial myopathy (IMMM), which is recognized by the presence of giant mitochondria in muscle tissue.
  • - Researchers analyzed data from the Mayo Clinic to identify five patients with cases of IMMM, who displayed symptoms like progressive muscle weakness, high creatine kinase levels, and specific muscle fiber characteristics.
  • - Treatment with immunomodulatory therapy showed improvements in most patients, and interestingly, all of them had simultaneous pancreatic diseases, suggesting a possible link that requires further investigation.
View Article and Find Full Text PDF

Nemaline myopathy (NM) is a rare congenital muscle disease that leads to muscle damage, resulting in muscle weakness and atrophy. Cases of scoliosis induced by muscle weakness and atrophy are exceedingly uncommon. The author clinically treated one patient with NM complicated by scoliosis and analyzed its clinical characteristics through a literature review.

View Article and Find Full Text PDF

Introduction And Aims: We describe a case of long-living COLQ-related congenital myasthenic syndrome (CMS) benefitting from ephedrine with an overall improvement quantified with functional measures.

Results: A 71-year-old man was referred with limb-girdle/axial myopathy and fatigability since infancy. In his thirties, a decremental response was observed at 3Hz-nerve stimulation, although testing seronegative for anti-neuromuscular junction antibodies.

View Article and Find Full Text PDF

Pathogenic variants in the type I ryanodine receptor (RYR1) result in a wide range of muscle disorders referred to as RYR1-related myopathies (RYR1-RM). We developed the first RYR1-RM mouse model resulting from co-inheritance of two different RYR1 missense alleles (Ryr1 mice). Ryr1 mice exhibit a severe, early onset myopathy characterized by decreased body/muscle mass, muscle weakness, hypotrophy, reduced RYR1 expression, and unexpectedly, incomplete postnatal lethality with a plateau survival of ~50% at 12 weeks of age.

View Article and Find Full Text PDF

A rare homozygous variant of induced severe cardiomyopathy and a cardiac conduction disorder: a case report.

Front Cardiovasc Med

October 2024

Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Article Synopsis
  • The choline kinase beta (CHKB) gene is vital for mitochondrial function and choline metabolism, and mutations can cause conditions like megaconial congenital muscular dystrophy (MCMD), leading to severe cardiac and neurological issues.
  • A case study involving a 13-year-old boy revealed a homozygous nonsense variant (c.598delC) in the CHKB gene, resulting in significant heart problems and neurological symptoms, while whole exome sequencing confirmed the pathogenic effect.
  • This research enhances our understanding of CHKB mutations' effects on patients and suggests that cardiac resynchronization therapy could be beneficial for those with choline metabolic disorders linked to heart complications.
View Article and Find Full Text PDF

Familial osteochondrodysplastic and cardiomyopathic syndrome in Chianina cattle.

J Vet Intern Med

November 2024

Institute of Genetics, Department of Clinical Research and Veterinary Public Health, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Background: Skeletal dysplasia encompasses a heterogeneous group of genetic disorders characterized by an abnormal development of bones, joints, and cartilage. Two Chianina half-sibling calves from consanguineous mating with congenital skeletal malformations and cardiac abnormalities were identified.

Hypothesis/objectives: To characterize the disease phenotype, to evaluate its genetic cause, and to determine the prevalence of the deleterious alleles in the Chianina population.

View Article and Find Full Text PDF

This paper discusses the cases of siblings that were born healthy, then diagnosed in their neonatal periods with cardiomyopathy and/or severe metabolic acidosis, which ran progressive courses and contributed to death in infancy. Molecular testing of the children confirmed the presence of an m.3303C>T point mutation in the mitochondrial DNA in the gene, which was also present in their oligosymptomatic mother and their mother's sister, an asymptomatic carrier.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between RNA alternative splicing abnormalities and physical function in children with congenital myotonic dystrophy (CDM), a severe form of myotonic dystrophy type 1 (DM1).
  • Researchers analyzed data from 82 participants, including adults with DM1 and children with CDM, assessing muscle biopsies, motor function, strength, and myotonia.
  • Results showed a significant correlation between myotonia and RNA mis-splicing in all DM1 individuals, while motor performance and strength were associated with splicing dysregulation, aiding future clinical trial designs for DM1 and CDM.
View Article and Find Full Text PDF

An increasing number of individuals with intellectual developmental disorder (IDD) and heterozygous variants in BCL11A are identified, yet our knowledge of manifestations and mutational spectrum is lacking. To address this, we performed detailed analysis of 42 individuals with BCL11A-related IDD (BCL11A-IDD, a.k.

View Article and Find Full Text PDF

Type 1 spinal muscular atrophy treated with nusinersen in Norway, a five-year follow-up.

Eur J Paediatr Neurol

November 2024

Department of Clinical Neurosciences for Children, Oslo University Hospital, Oslo, Norway; Section for Rare Neuromuscular Disorders and Unit for Congenital and Hereditary Neuromuscular Disorders (EMAN), Department of Neurology, Oslo University Hospital, Oslo, Norway.

Article Synopsis
  • New treatments for 5q spinal muscular atrophy (SMA) have changed how the disease presents, but there are ongoing questions about their long-term effectiveness, particularly for patients treated with nusinersen in Norway.
  • A study followed ten SMA type 1 patients over five years, using various assessments to track their motor function and other health metrics, with most patients remaining alive and treated by the end of the study.
  • Results showed initial motor function improvements, particularly in younger patients; however, after 38 months, these improvements plateaued, and there were no significant enhancements in bulbar and respiratory functions, affirming nusinersen's safety and partial effectiveness.
View Article and Find Full Text PDF

Background: SELENON-related myopathy (SELENON-RM) is a rare congenital myopathy characterized by slowly progressive axial muscle weakness, rigidity of the spine, scoliosis, and respiratory insufficiency. Laminin-a2-related muscular dystrophy (LAMA2-MD) has a similar clinical phenotype, which ranges from severe, early-onset congenital muscular dystrophy type 1A (MDC1A) to milder forms presenting as childhood- or adult-onset limb-girdle type muscular dystrophy. The first 1.

View Article and Find Full Text PDF
Article Synopsis
  • - Positional plagiocephaly is the most common form of craniofacial malformation in infants, often linked to factors like sleeping on their back, multiple births, and congenital issues like muscular torticollis.
  • - Diagnosis is made through physical exams and, in more severe cases, 3D imaging techniques are used to assess the skull shape noninvasively.
  • - Treatment usually involves repositioning the infant, with orthotic therapy for more serious cases, showing best results when started between 4 to 7 months of age, lasting around 2 to 6 months.
View Article and Find Full Text PDF

275th ENMC international workshop: Seronegative myasthenia gravis: An update paradigm for diagnosis and management, 9-11 February 2024, Hoofddorp, the Netherlands.

Neuromuscul Disord

November 2024

Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Instituto Neurologico Carlo Besta, Milano, Italy. Electronic address:

The 275th ENMC workshop on the diagnosis and management of seronegative myasthenia gravis (SNMG) was held on February 9-11, 2024. The participants included experts in the field of adult and pediatric MG together with patient representatives. This workshop aimed to redefine SNMG in view of recent diagnostic and therapeutic updates and to identify patient unmet needs.

View Article and Find Full Text PDF

Aligning with the 3Rs: alternative models for research into muscle development and inherited myopathies.

BMC Vet Res

October 2024

Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, Faculty of Health and Lifesciences, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX, UK.

Inherited and acquired muscle diseases are an important cause of morbidity and mortality in human medical and veterinary patients. Researchers use models to study skeletal muscle development and pathology, improve our understanding of disease pathogenesis and explore new treatment options. Experiments on laboratory animals, including murine and canine models, have led to huge advances in congenital myopathy and muscular dystrophy research that have translated into clinical treatment trials in human patients with these debilitating and often fatal conditions.

View Article and Find Full Text PDF

Pathogenic variants in the ryanodine receptor 1 () gene are causative for a wide spectrum of muscular phenotypes, ranging from malignant hyperthermia over mild, non-progressive to severe congenital myopathy. Both autosomal dominant and recessive inheritance can occur, with the more severe forms usually showing recessive inheritance. However, genotype-phenotype correlations are complicated due to the large size of the gene and heterogeneous phenotypes.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic variants in the FKRP gene cause various muscular dystrophies, including Limb-Girdle Muscular Dystrophy type 9 (LGMDR9), which is notably prevalent in Italy.
  • A study analyzed 153 patients from Southern Italy showing Duchenne/Becker-like symptoms, identifying pathogenic variants in 16 individuals, with specific variants frequently found.
  • The findings emphasize the need to include LGMDR9 in the diagnosis of dystrophinopathies, aiming to improve the identification and management of affected patients in Calabria.
View Article and Find Full Text PDF

Background: Spinal muscular atrophy is an inherited neurodegenerative disorder that typically leads to severe physical disability. The present study aimed to determine the subjective evaluation of this disorder screening and analyze its influencing factors in Iran.

Methods: A cross-sectional study was performed using data from the second survey of women either pregnant or planning to become pregnant in Tehran, the capital of Iran, in 2022.

View Article and Find Full Text PDF